Cinacalcet metabolite M4

CAS No. 104774-87-0

Cinacalcet metabolite M4( Rarechem AL BW 1078 )

Catalog No. M26115 CAS No. 104774-87-0

Cinacalcet metabolite M4 is a metabolite of Cinacalcet. Cinacalcet is an allosteric agonist of Ca receptor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 45 In Stock
5MG 48 In Stock
10MG 65 In Stock
25MG 92 In Stock
50MG 129 In Stock
100MG 166 In Stock
200MG 238 In Stock
500MG 357 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Cinacalcet metabolite M4
  • Note
    Research use only, not for human use.
  • Brief Description
    Cinacalcet metabolite M4 is a metabolite of Cinacalcet. Cinacalcet is an allosteric agonist of Ca receptor.
  • Description
    Cinacalcet metabolite M4 is a metabolite of Cinacalcet. Cinacalcet is an allosteric agonist of Ca receptor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Rarechem AL BW 1078
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    104774-87-0
  • Formula Weight
    203.208
  • Molecular Formula
    C10H12F3N
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    NCCCc1cccc(c1)C(F)(F)F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.J.L.M.Heeremans, et al. Interference of ?-amino-caproic acid with [N-succinimidyl S-acetylthioacetate derived] thiol-introduction into glu-plasminogen. Volume 8, Supplement 2, 1994, Pages 138-141.
molnova catalog
related products
  • Bepridil hydrochlori...

    Bepridil is a calcium channel blocker and also inhibits Na+/Ca2+ exchange (NCX) sodium channels and cardiac sarcolemmal KATP channels.

  • Lacidipine

    Lacidipine (Lacipil, Motens) is a L-type calcium channel blocker.

  • Atagabalin

    Atagabalin (PD 0200390) is a novel ligand of the voltage-dependent calcium channel (VDCC) α2δ subunit (1 and 2) for treatment for insomnia.